XTSENUMI
Market cap8mUSD
Jan 02, Last price
0.04CAD
1D
0.00%
1Q
33.33%
Name
Numinus Wellness Inc
Chart & Performance
P/E
—
P/S
0.56
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
23m
+256.95%
Net income
-30m
L-32.59%
CFO
-23m
L-13.23%
Earnings
Jan 13, 2025
Profile
Numinus Wellness Inc. provides solutions to develop and deliver psychedelic-assisted psychotherapy and transform the mental health landscape. The company operates in two divisions, Salvation Botanicals and Numinus Health. The Salvation Botanicals division offers laboratory services, such as cultivation, analytical testing, product research and development, and ancillary services in the area of psychedelics; and full suite testing and custom testing of cannabis. The Numinus Health division provides supportive therapies and technologies to heal, connect, and grow with a focus on treating mental health and substance abuse; and services for psychotherapy, counselling, neurofeedback, physiotherapy, and other therapies. This division also offers training, facilities, and other operational resources to practitioners. The company is headquartered in Vancouver, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑08 | 2022‑08 | 2021‑08 | 2020‑08 | 2019‑08 | 2018‑08 | 2017‑07 | 2016‑07 | |
| Income | ||||||||
Revenues | 23,180 256.95% | 6,494 329.03% | ||||||
Cost of revenue | 48,499 | 33,962 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | (25,319) | (27,468) | ||||||
NOPBT Margin | ||||||||
Operating Taxes | (34) | |||||||
Tax Rate | ||||||||
NOPAT | (25,319) | (27,434) | ||||||
Net income | (30,256) -32.59% | (44,882) 139.06% | ||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 916 | 692 | ||||||
BB yield | -1.78% | -0.89% | ||||||
| Debt | ||||||||
Debt current | 1,557 | 1,442 | ||||||
Long-term debt | 12,607 | 13,982 | ||||||
Deferred revenue | ||||||||
Other long-term liabilities | 425 | |||||||
Net debt | 3,508 | (19,991) | ||||||
| Cash flow | ||||||||
Cash from operating activities | (22,760) | (26,230) | ||||||
CAPEX | (375) | (1,246) | ||||||
Cash from investing activities | (370) | 123 | ||||||
Cash from financing activities | (1,458) | 7 | ||||||
FCF | (24,120) | (35,501) | ||||||
| Balance | ||||||||
Cash | 8,580 | 33,044 | ||||||
Long term investments | 2,077 | 2,372 | ||||||
Excess cash | 9,497 | 35,091 | ||||||
Stockholders' equity | 14,049 | 40,126 | ||||||
Invested Capital | 11,751 | 14,399 | ||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | 263,632 | 216,587 | ||||||
Price | 0.20 -45.83% | 0.36 -57.65% | ||||||
Market cap | 51,408 -34.07% | 77,971 -44.39% | ||||||
EV | 54,916 | 57,980 | ||||||
EBITDA | (22,485) | (25,963) | ||||||
EV/EBITDA | ||||||||
Interest | 760 | 558 | ||||||
Interest/NOPBT | ||||||||